Current perspectives for metabolomics and lipidomics in dyslipidemia of acne vulgaris: a mini review

Acne vulgaris (AV) is a common inflammatory disorder involving the pilosebaceous unit. Many studies have reported that people with AV have higher levels of total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-c) compared to healthy controls. Hence, they concluded...

Full description

Saved in:
Bibliographic Details
Main Authors: Liang Wu, Sheng-Cai Zhu, Yang He, Yun-Xia Zhu, Xiao-Liang Ou-Yang, Deng Zhang, Chun-Ming Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1538373/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841527928986271744
author Liang Wu
Sheng-Cai Zhu
Yang He
Yun-Xia Zhu
Xiao-Liang Ou-Yang
Deng Zhang
Chun-Ming Li
author_facet Liang Wu
Sheng-Cai Zhu
Yang He
Yun-Xia Zhu
Xiao-Liang Ou-Yang
Deng Zhang
Chun-Ming Li
author_sort Liang Wu
collection DOAJ
description Acne vulgaris (AV) is a common inflammatory disorder involving the pilosebaceous unit. Many studies have reported that people with AV have higher levels of total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-c) compared to healthy controls. Hence, they concluded that an unhealthy lipid profile is an independent risk factor for AV. Recent research in metabolomics and lipidomics has been propelled by rapid advancements in technologies including computational methods and mass spectrometry. Using metabolomics and lipidomics approach, a broad range of structurally diverse lipid species were detected and important lipid biomarkers were identified that are vital to the pathogenesis of AV. In this review, we will describe the recent progress in dyslipidemia of AV using metabolomics and lipidomics advances. We will begin with a literature overview of dyslipidemia of AV, followed by a short introduction of metabolomics and lipidomics. Finally, we will focus on applying metabolomics and lipidomics in dyslipidemia of AV.
format Article
id doaj-art-cbed5114332840b384cb0cf9eb9b17e7
institution Kabale University
issn 2296-858X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-cbed5114332840b384cb0cf9eb9b17e72025-01-15T05:11:08ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-01-011110.3389/fmed.2024.15383731538373Current perspectives for metabolomics and lipidomics in dyslipidemia of acne vulgaris: a mini reviewLiang Wu0Sheng-Cai Zhu1Yang He2Yun-Xia Zhu3Xiao-Liang Ou-Yang4Deng Zhang5Chun-Ming Li6Department of Dermatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, ChinaDepartment of Dermatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, ChinaDepartment of Dermatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, ChinaDepartment of Dermatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, ChinaDepartment of Plastic Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, ChinaDepartment of Dermatology, The Fifth People's Hospital Affiliated to Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaDepartment of Dermatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, ChinaAcne vulgaris (AV) is a common inflammatory disorder involving the pilosebaceous unit. Many studies have reported that people with AV have higher levels of total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-c) compared to healthy controls. Hence, they concluded that an unhealthy lipid profile is an independent risk factor for AV. Recent research in metabolomics and lipidomics has been propelled by rapid advancements in technologies including computational methods and mass spectrometry. Using metabolomics and lipidomics approach, a broad range of structurally diverse lipid species were detected and important lipid biomarkers were identified that are vital to the pathogenesis of AV. In this review, we will describe the recent progress in dyslipidemia of AV using metabolomics and lipidomics advances. We will begin with a literature overview of dyslipidemia of AV, followed by a short introduction of metabolomics and lipidomics. Finally, we will focus on applying metabolomics and lipidomics in dyslipidemia of AV.https://www.frontiersin.org/articles/10.3389/fmed.2024.1538373/fullacne vulgarisdyslipidemiametabolomicslipidomicssphingomyelinsphosphatidylcholines
spellingShingle Liang Wu
Sheng-Cai Zhu
Yang He
Yun-Xia Zhu
Xiao-Liang Ou-Yang
Deng Zhang
Chun-Ming Li
Current perspectives for metabolomics and lipidomics in dyslipidemia of acne vulgaris: a mini review
Frontiers in Medicine
acne vulgaris
dyslipidemia
metabolomics
lipidomics
sphingomyelins
phosphatidylcholines
title Current perspectives for metabolomics and lipidomics in dyslipidemia of acne vulgaris: a mini review
title_full Current perspectives for metabolomics and lipidomics in dyslipidemia of acne vulgaris: a mini review
title_fullStr Current perspectives for metabolomics and lipidomics in dyslipidemia of acne vulgaris: a mini review
title_full_unstemmed Current perspectives for metabolomics and lipidomics in dyslipidemia of acne vulgaris: a mini review
title_short Current perspectives for metabolomics and lipidomics in dyslipidemia of acne vulgaris: a mini review
title_sort current perspectives for metabolomics and lipidomics in dyslipidemia of acne vulgaris a mini review
topic acne vulgaris
dyslipidemia
metabolomics
lipidomics
sphingomyelins
phosphatidylcholines
url https://www.frontiersin.org/articles/10.3389/fmed.2024.1538373/full
work_keys_str_mv AT liangwu currentperspectivesformetabolomicsandlipidomicsindyslipidemiaofacnevulgarisaminireview
AT shengcaizhu currentperspectivesformetabolomicsandlipidomicsindyslipidemiaofacnevulgarisaminireview
AT yanghe currentperspectivesformetabolomicsandlipidomicsindyslipidemiaofacnevulgarisaminireview
AT yunxiazhu currentperspectivesformetabolomicsandlipidomicsindyslipidemiaofacnevulgarisaminireview
AT xiaoliangouyang currentperspectivesformetabolomicsandlipidomicsindyslipidemiaofacnevulgarisaminireview
AT dengzhang currentperspectivesformetabolomicsandlipidomicsindyslipidemiaofacnevulgarisaminireview
AT chunmingli currentperspectivesformetabolomicsandlipidomicsindyslipidemiaofacnevulgarisaminireview